Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd. (ACBM) Revenue
Annual & quarterly revenue history · segment & region breakdown
ACBM · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAcro Biomedical Co., Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Acro Biomedical Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Acro Biomedical Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Acro Biomedical Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ACBM revenue · 4 questionsACBM's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Acro Biomedical Co., Ltd. SEC filings · GAAP · Acro Biomedical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026